Prevention of nausea & vomiting associated w/ moderately emetogenic cancer chemotherapy Adult 8 mg twice daily. Administer 1st dose 30 min prior to chemotherapy w/ subsequent dose 4-8 hrly. Thereafter, 8 mg twice daily for 1-2 days after completion of chemotherapy.
Childn 4-12 yr 4 mg 3 times daily.
Prevention of nausea & vomiting associated w/ RT 8 mg 1-2 hr prior to RT w/ subsequent doses 8 hrly after the 1st dose.
Post-op nausea & vomiting 16 mg as single dose 1 hr prior to anaesth induction.